199 related articles for article (PubMed ID: 19473295)
21. Diffusely abnormal white matter in multiple sclerosis: further histologic studies provide evidence for a primary lipid abnormality with neurodegeneration.
Laule C; Pavlova V; Leung E; Zhao G; MacKay AL; Kozlowski P; Traboulsee AL; Li DK; Moore GR
J Neuropathol Exp Neurol; 2013 Jan; 72(1):42-52. PubMed ID: 23242281
[TBL] [Abstract][Full Text] [Related]
22. A Gradient of neuronal loss and meningeal inflammation in multiple sclerosis.
Magliozzi R; Howell OW; Reeves C; Roncaroli F; Nicholas R; Serafini B; Aloisi F; Reynolds R
Ann Neurol; 2010 Oct; 68(4):477-93. PubMed ID: 20976767
[TBL] [Abstract][Full Text] [Related]
23. Schwann cell remyelination of demyelinated axons in spinal cord multiple sclerosis lesions.
Itoyama Y; Webster HD; Richardson EP; Trapp BD
Ann Neurol; 1983 Sep; 14(3):339-46. PubMed ID: 6195956
[TBL] [Abstract][Full Text] [Related]
24. Autoreactive T and B cells responding to myelin proteolipid protein in multiple sclerosis and controls.
Sun JB; Olsson T; Wang WZ; Xiao BG; Kostulas V; Fredrikson S; Ekre HP; Link H
Eur J Immunol; 1991 Jun; 21(6):1461-8. PubMed ID: 1710567
[TBL] [Abstract][Full Text] [Related]
25. Studies of myelin proteins in multiple sclerosis brain tissue.
Trotter JL; Wegescheide CL; Garvey WF; Tourtellotte WW
Neurochem Res; 1984 Jan; 9(1):147-52. PubMed ID: 6201757
[TBL] [Abstract][Full Text] [Related]
26. Extensive loss of connexins in Baló's disease: evidence for an auto-antibody-independent astrocytopathy via impaired astrocyte-oligodendrocyte/myelin interaction.
Masaki K; Suzuki SO; Matsushita T; Yonekawa T; Matsuoka T; Isobe N; Motomura K; Wu XM; Tabira T; Iwaki T; Kira J
Acta Neuropathol; 2012 Jun; 123(6):887-900. PubMed ID: 22438105
[TBL] [Abstract][Full Text] [Related]
27. The relative number of macrophages/microglia expressing macrophage colony-stimulating factor and its receptor decreases in multiple sclerosis lesions.
Werner K; Bitsch A; Bunkowski S; Hemmerlein B; Brück W
Glia; 2002 Oct; 40(1):121-9. PubMed ID: 12237849
[TBL] [Abstract][Full Text] [Related]
28. Immune regulation of multiple sclerosis by transdermally applied myelin peptides.
Juryńczyk M; Walczak A; Jurewicz A; Jesionek-Kupnicka D; Szczepanik M; Selmaj K
Ann Neurol; 2010 Nov; 68(5):593-601. PubMed ID: 21031576
[TBL] [Abstract][Full Text] [Related]
29. T-cell responses to myelin antigens in multiple sclerosis; relevance of the predominant autoimmune reactivity to myelin oligodendrocyte glycoprotein.
de Rosbo NK; Ben-Nun A
J Autoimmun; 1998 Aug; 11(4):287-99. PubMed ID: 9776706
[TBL] [Abstract][Full Text] [Related]
30. The distribution of myelin basic protein in central nervous system lesions of multiple sclerosis and acute experimental allergic encephalomyelitis.
Whitaker JN
Ann Neurol; 1978 Apr; 3(4):291-8. PubMed ID: 78682
[TBL] [Abstract][Full Text] [Related]
31. Multiple sclerosis. Oligodendrocyte proliferation and differentiation in fresh lesions.
Prineas JW; Kwon EE; Goldenberg PZ; Ilyas AA; Quarles RH; Benjamins JA; Sprinkle TJ
Lab Invest; 1989 Nov; 61(5):489-503. PubMed ID: 2811298
[TBL] [Abstract][Full Text] [Related]
32. Influence of neurosteroids on the pathogenesis of multiple sclerosis.
Leitner H
Med Hypotheses; 2010 Aug; 75(2):229-34. PubMed ID: 20227191
[TBL] [Abstract][Full Text] [Related]
33. Oligodendrocytes in the early course of multiple sclerosis.
Brück W; Schmied M; Suchanek G; Brück Y; Breitschopf H; Poser S; Piddlesden S; Lassmann H
Ann Neurol; 1994 Jan; 35(1):65-73. PubMed ID: 8285595
[TBL] [Abstract][Full Text] [Related]
34. Myelin phagocytosis and remyelination of macrophage-enriched central nervous system aggregate cultures.
Copelman CA; Diemel LT; Gveric D; Gregson NA; Cuzner ML
J Neurosci Res; 2001 Dec; 66(6):1173-8. PubMed ID: 11746450
[TBL] [Abstract][Full Text] [Related]
35. Heat shock protein 70 associations with myelin basic protein and proteolipid protein in multiple sclerosis brains.
Cwiklinska H; Mycko MP; Luvsannorov O; Walkowiak B; Brosnan CF; Raine CS; Selmaj KW
Int Immunol; 2003 Feb; 15(2):241-9. PubMed ID: 12578854
[TBL] [Abstract][Full Text] [Related]
36. A quantitative analysis of oligodendrocytes in multiple sclerosis lesions. A study of 113 cases.
Lucchinetti C; Brück W; Parisi J; Scheithauer B; Rodriguez M; Lassmann H
Brain; 1999 Dec; 122 ( Pt 12)():2279-95. PubMed ID: 10581222
[TBL] [Abstract][Full Text] [Related]
37. Myelin in multiple sclerosis is developmentally immature.
Moscarello MA; Wood DD; Ackerley C; Boulias C
J Clin Invest; 1994 Jul; 94(1):146-54. PubMed ID: 7518827
[TBL] [Abstract][Full Text] [Related]
38. T and B cell responses to myelin-oligodendrocyte glycoprotein in multiple sclerosis.
Sun J; Link H; Olsson T; Xiao BG; Andersson G; Ekre HP; Linington C; Diener P
J Immunol; 1991 Mar; 146(5):1490-5. PubMed ID: 1899688
[TBL] [Abstract][Full Text] [Related]
39. Brain-derived antigens in lymphoid tissue of patients with acute stroke.
Planas AM; Gómez-Choco M; Urra X; Gorina R; Caballero M; Chamorro Á
J Immunol; 2012 Mar; 188(5):2156-63. PubMed ID: 22287710
[TBL] [Abstract][Full Text] [Related]
40. Immunoglobulins and complement in postmortem multiple sclerosis tissue.
Barnett MH; Parratt JD; Cho ES; Prineas JW
Ann Neurol; 2009 Jan; 65(1):32-46. PubMed ID: 19194879
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
